Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter

To determine whether Seraph-100 (Exthera Medical Corporation, Martinez, CA) treatment provides clinical benefit for severe coronavirus disease 2019 cases that require mechanical ventilation and vasopressor support. DATA SOURCES: The first two patients in the United States treated with the novel Sera...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Crit Care Explor
Hlavní autoři: Olson, Stephen W., Oliver, James D., Collen, Jacob, Bunin, Jessica, Gleeson, Todd D., Foster, Brian E., Simmons, Mark P., Chen, Hua W., Ficke, Jennifer B., Brown, Tara E., Nau, Mark T., Cebula, Brennan R., Kielstein, Jan, Chung, Kevin K.
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396271/
https://ncbi.nlm.nih.gov/pubmed/32766569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCE.0000000000000180
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky